Browsing Category

Supplier News

195 posts

The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.

Terumo Investing $500 M To Expand CDMO & Drug-Delivery Capabilities
By

By
Marco Chiadò Piat, President, Pharmaceutical Solutions Division, Terumo Medical Solutions, outlined a $500-million expansion plan, which includes an acquisition and organic growth, at the DCAT Member Company Announcement Forum, held…

Agno Pharma Expanding Small-Molecule API and Drug-Product Mfg
By

By
James Chen, CEO, Agno Pharmaceuticals, outlined the company’s expansion activity in small-molecule active pharmaceutical ingredients (APIs) and GMP intermediates and drug-product development and manufacturing, at the DCAT Member Company Announcement…

West Pharmaceutical Services Highlights Key Capital Projects in Contract Mfg Business
By

By
Aileen Ruff-Patry, President, Contract Manufacturing, West Pharmaceutical Services, outlined recent expansions by the company to support development and commercialization of medical devices, drug-delivery systems, and combination products through manufacturing, device…

Wilmington PharmaTech Expanding Small-Molecule API Mfg
By

By
In late 2025, Wilmington PharmaTech, a US-based active parmaceutical ingredient (API), announced a partnership with Curewell Capital, a healthcare-focused private equity firm, to support the company’s continued expansion. Kent Payne,…

Grand River Aseptic Manufacturing Expanding Sterile Injectable Mfg Capacity
By

By
Denis Johnson, CEO, Grand River Aseptic Manufacturing (GRAM), a CDMO of injectables, is expanding its capabilities in response to increasing demand for sterile manufacturing in the US. As part of…

Axplora Expanding to Support HPAPI Production
By

By
Martin Meeson, CEO of Axplora, a CDMO of active pharmaceutical ingredient (API) manufacturing, highlighted the company’s $60-million investment program at the company’s Farmabios site in Gropello Cairoli, Italy, at the…

Boston Institute of Biotechnology Announces Biomanufacturing Expansions
By

By
Peng Jiao, PhD, CEO, of the Boston Institute of Biotechnology (BIB), outlined the company’s biomanufacturing expansions at the DCAT Member Company Announcement Forum, held March 23, 2026, at DCAT Week.…

BSP Pharmaceuticals Outlines $800-M-Plus Expansion Plan
By

By
BSP Pharmaceuticals is advancing a major expansion of its manufacturing capacity, as part of a revised mid- to long-term strategic plan, designed to support growing global demand for complex biologics…

HAS Healthcare Advanced Synthesis Group Announces $120-M Expansion Plan; Integration of Cerbios-Pharma
By

By
Waldo Mossi, CEO, HAS Healthcare Advanced Synthesis Group, outlined the company’s expansion plan and integration of its acquisition of the CDMO Cerbios-Pharma at the DCAT Member Company Announcement Forum, held…

Start-up Allos AI Announces Seed Funding for AI-Enabled Pharma R&D, Formulation Development
By

By
Aditya Iyer, PhD, CEO and co-founder of Allos AI, a start-up company applying causal artificial intelligence (AI) to pharmaceutical research and development, including formulation development, outlined the company’s strategy and…